Mutations in the G6PC3 gene cause Dursun syndrome

Published on Oct 1, 2010in American Journal of Medical Genetics Part A
· DOI :10.1002/AJMG.A.33615
Siddharth Banka27
Estimated H-index: 27
(St Mary's Hospital),
William G. Newman63
Estimated H-index: 63
(St Mary's Hospital)
+ 1 AuthorsAli Dursun16
Estimated H-index: 16
(Boston Children's Hospital)
Sources
Abstract
Dursun syndrome is a triad of familial primary pulmonary hypertension, leucopenia, and atrial septal defect. Here we demonstrate that mutations in G6PC3 cause Dursun syndrome. Mutations in G6PC3 are known to also cause severe congenital neutropenia type 4. Identification of the genetic basis of Dursun syndrome expands the pre-existing knowledge about the phenotypic effects of mutations in G6PC3. We propose that Dursun syndrome should now be considered as a subset of severe congenital neutropenia type 4 with pulmonary hypertension as an important clinical feature.
📖 Papers frequently viewed together
290 Citations
201017.54Blood
67 Citations
38 Citations
References10
Newest
#1Siddharth Banka (St Mary's Hospital)H-Index: 27
#2Elena Chervinsky (Emek Medical Center)H-Index: 7
Last. Stavit A. Shalev (Emek Medical Center)H-Index: 38
view all 8 authors...
Severe congenital neutropenia type 4 (SCN4) is an autosomal recessive condition, which was defined recently with identification of the causative mutations in G6PC3. To date there are only three reports in the literature describing patients with SCN4 with mutations in the G6PC3 gene. We report four individuals with SCN4 who belong to a single large consanguineous kindred. We provide an overview of the non-haematological features of the condition with a focus on the adult phenotype, which has not ...
38 CitationsSource
#1Hyun Sik Jun (NIH: National Institutes of Health)H-Index: 15
#2Young Mok Lee (NIH: National Institutes of Health)H-Index: 15
Last. Janice Y. Chou (NIH: National Institutes of Health)H-Index: 24
view all 8 authors...
G6PC3 deficiency, characterized by neutropenia and neutrophil dysfunction, is caused by deficiencies in the endoplasmic reticulum (ER) enzyme glucose-6-phosphatase-β (G6Pase-β or G6PC3) that converts glucose-6-phosphate (G6P) into glucose, the primary energy source of neutrophils. Enhanced neutrophil ER stress and apoptosis underlie neutropenia in G6PC3 deficiency, but the exact functional role of G6Pase-β in neutrophils remains unknown. We hypothesized that the ER recycles G6Pase-β–generated gl...
93 CitationsSource
#1Manuela Germeshausen (Hochschule Hannover)H-Index: 27
#2Cornelia ZeidlerH-Index: 34
Last. Karl WelteH-Index: 87
view all 6 authors...
Severe congenital neutropenia a clinically and genetically heterogeneous disorder. Mutations in different genes have been described as causative for severe neutropenia, e.g. ELANE, HAX1 and G6PC3. Although congenital neutropenia is considered to be a group of monogenic disorders, the phenotypic heterogeneity even within the yet defined genetic subtypes points to additional genetic and/or epigenetic influences on the disease phenotype. We describe congenital neutropenia patients with mutations in...
67 CitationsSource
#1Kaan Boztug (MHH: Hannover Medical School)H-Index: 36
#2Giridharan Appaswamy (MHH: Hannover Medical School)H-Index: 5
Last. Christoph KleinH-Index: 65
view all 26 authors...
Background The main features of severe congenital neutropenia are the onset of severe bacterial infections early in life, a paucity of mature neutrophils, and an increased risk of leukemia. In many patients, the genetic causes of severe congenital neutropenia are unknown. Methods We performed genomewide genotyping and linkage analysis on two consanguineous pedigrees with a total of five children affected with severe congenital neutropenia. Candidate genes from the linkage interval were sequenced...
290 CitationsSource
#1Jun Xia (WashU: Washington University in St. Louis)H-Index: 9
#2Audrey Anna Bolyard (UW: University of Washington)H-Index: 20
Last. Daniel C. Link (WashU: Washington University in St. Louis)H-Index: 82
view all 7 authors...
Severe congenital neutropenia (SCN) is a genetically heterogeneous syndrome associated with mutations of ELANE (ELA2), HAX1, GFI1, WAS, CSF3R or G6PC3. We investigated the prevalence of mutations of ELANE in a cohort of 162 SCN patients for whom blood or bone marrow samples were submitted to the North American Severe Chronic Neutropenia Tissue Repository. Mutations of ELANE were found in 90 of 162 patients (55.6%). Subsequently, we conducted an analysis of a subset of 73 of these cases utilizing...
160 CitationsSource
#1John C. Hutton (University of Colorado Denver)H-Index: 72
#2Richard M. O'Brien (Vandy: Vanderbilt University)H-Index: 52
Glucose-6-phosphatase catalyzes the hydrolysis of glucose 6-phosphate (G6P) to glucose and inorganic phosphate. It is a multicomponent system located in the endoplasmic reticulum that comprises several integral membrane proteins, namely a catalytic subunit (G6PC) and transporters for G6P, inorganic phosphate, and glucose. The G6PC gene family contains three members, designated G6PC, G6PC2, and G6PC3. The tissue-specific expression patterns of these genes differ, and mutations in all three genes ...
148 CitationsSource
#1Juan I. ArósteguiH-Index: 40
Last. Cristina Díaz de HerediaH-Index: 20
view all 6 authors...
To the editor: Hereditary severe congenital neutropenia (SCN) represents a heterogeneous group of diseases characterized by early-onset life-threatening bacterial infections associated with absolute neutrophil counts (ANC) below 500/μL.[1][1],[2][2] In recent years, different studies have
28 CitationsSource
#1Prateek Kumar (JCVI: J. Craig Venter Institute)H-Index: 3
#2Steven Henikoff (Fred Hutchinson Cancer Research Center)H-Index: 141
Last. Pauline C. Ng (JCVI: J. Craig Venter Institute)H-Index: 13
view all 3 authors...
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
5,677 CitationsSource
#1Ali Dursun (Hacettepe University)H-Index: 16
#2R. Koksal OzgulH-Index: 2
Last. Jane H. MorseH-Index: 23
view all 10 authors...
We present two siblings with identical clinical findings that seem to represent a previously unreported familial syndrome. Major findings involve three systems: pulmonary arterial hypertension, cardiac abnormalities including secundum-type atrial septal defect, and the hematopoietic system with inte
18 CitationsSource
#1Marc HumbertH-Index: 163
#2Philippe LabruneH-Index: 27
Last. Gérald SimonneauH-Index: 138
view all 3 authors...
Pulmonary arterial hypertension is characterised by the presence of pulmonary hypertension (mean pulmonary artery pressure > 25 mmHg at rest or >30 mmHg during exercise) and normal pulmonary wedge pressure (<12 mmHg). Several risk factors for pulmonary arterial hypertension have been described. In the absence of any factor or condition suspected to play a causal or facilitating role in the process, pulmonary hypertension is “unexplained” (primary pulmonary hypertension, PPH). PPH is a rare condi...
19 CitationsSource
Cited By27
Newest
#1Bobby G. Ng (DI: Discovery Institute)H-Index: 26
#2Paulina Sosicka (DI: Discovery Institute)H-Index: 9
Last. Hudson H. Freeze (DI: Discovery Institute)H-Index: 79
view all 32 authors...
Summary SLC37A4 encodes an endoplasmic reticulum (ER)-localized multitransmembrane protein required for transporting glucose-6-phosphate (Glc-6P) into the ER. Once transported into the ER, Glc-6P is subsequently hydrolyzed by tissue-specific phosphatases to glucose and inorganic phosphate during times of glucose depletion. Pathogenic variants in SLC37A4 cause an established recessive disorder known as glycogen storage disorder 1b characterized by liver and kidney dysfunction with neutropenia. We...
Source
#1Eva M. GalvezH-Index: 16
#2Elena Vallespín (CSIC: Spanish National Research Council)H-Index: 20
Last. Montserrat Peiró (Autonomous University of Barcelona)H-Index: 1
view all 25 authors...
Inherited bone marrow failure syndromes (IBMFSs) are a group of congenital rare diseases characterized by bone marrow failure, congenital anomalies, high genetic heterogeneity, and predisposition to cancer. Appropriate treatment and cancer surveillance ideally depend on the identification of the mutated gene. A next-generation sequencing (NGS) panel of genes could be 1 initial genetic screening test to be carried out in a comprehensive study of IBMFSs, allowing molecular detection in affected pa...
1 CitationsSource
#1Majed DasoukiH-Index: 11
Last. Syed Osman AhmedH-Index: 7
view all 16 authors...
Abstract Autosomal recessive mutations in G6PC3 cause isolated and syndromic congenital neutropenia which includes congenital heart disease and atypical inflammatory bowel disease (IBD). In a highly consanguineous pedigree with novel mutations in G6PC3 and MPL, we performed comprehensive multi-omics analyses. Structural analysis of variant G6PC3 and MPL proteins suggests a damaging effect. A distinct molecular cytokine profile (cytokinome) in the affected proband with IBD was detected. Liquid ch...
Source
#1Carlota Pascoal (NOVA: Universidade Nova de Lisboa)H-Index: 8
#2Rita Francisco (NOVA: Universidade Nova de Lisboa)H-Index: 18
Last. Paula A. Videira (NOVA: Universidade Nova de Lisboa)H-Index: 27
view all 6 authors...
: Glycosylation is an essential biological process that adds structural and functional diversity to cells and molecules, participating in physiological processes such as immunity. The immune response is driven and modulated by protein-attached glycans that mediate cell-cell interactions, pathogen recognition and cell activation. Therefore, abnormal glycosylation can be associated with deranged immune responses. Within human diseases presenting immunological defects are congenital disorders of gl...
16 CitationsSource
#1Jonathan Spoor (Tehran University of Medical Sciences)H-Index: 3
#2Hamid Farajifard (Tehran University of Medical Sciences)H-Index: 3
Last. Nima Rezaei (Tehran University of Medical Sciences)H-Index: 80
view all 3 authors...
Abstract Neutropenia is a dangerous and potentially fatal condition that renders patients vulnerable to recurrent infections. Its severity is commensurate with the absolute count of neutrophil granulocytes in the circulation. In paediatric patients, neutropenia can have many different aetiologies. Primary causes make up but a small portion of the whole and are relatively unknown. In the past decades, a number of genes has been discovered that are responsible for congenital neutropenia. By pertur...
6 CitationsSource
#1Ayca Kiykim (Austrian Academy of Sciences)H-Index: 14
#2Safa BarisH-Index: 22
Last. Isil BarlanH-Index: 31
view all 9 authors...
Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency was recently defined as a new severe congenital neutropenia subgroup remarkable with congenital heart defects, urogenital malformations, endocrine abnormalities, and prominent superficial veins. Here, we report 3 patients with G6PC3 deficiency presenting with recurrent diarrhea, failure to thrive, and sinopulmonary infections leading to bronchiectasis. In patient I and II, a combined immune deficiency was suspected due to early-onset d...
16 CitationsSource
#1Jonathan J. Lyons (NIH: National Institutes of Health)H-Index: 20
#2Joshua D. Milner (NIH: National Institutes of Health)H-Index: 51
Last. Sergio D. Rosenzweig (NIH: National Institutes of Health)H-Index: 42
view all 3 authors...
Protein glycosylation is an important epigenetic modifying process affecting expression, localization, and function of numerous proteins required for normal immune function. Recessive germline mutations in genes responsible for protein glycosylation processes result in congenital disorders of glycosylation (CDGs) and can have profound immunologic consequences. Genetic mutations in immune signaling pathways that affect glycosylation sites have also been shown to cause disease. Sugar supplementati...
38 CitationsSource
#1Su-Ru Lin (NIH: National Institutes of Health)H-Index: 9
#2Chi-Jiunn Pan (NIH: National Institutes of Health)H-Index: 26
Last. Janice Yang Chou (NIH: National Institutes of Health)H-Index: 36
view all 4 authors...
Abstract Glucose-6-phosphatase-β (G6Pase-β or G6PC3) deficiency is characterized by neutropenia and dysfunction in both neutrophils and macrophages. G6Pase-β is an enzyme embedded in the endoplasmic reticulum membrane that catalyzes the hydrolysis of glucose-6-phosphate (G6P) to glucose and phosphate. To date, 33 separate G6PC3 mutations have been identified in G6Pase-β-deficient patients but only the p.R253H and p.G260R missense mutations have been characterized functionally for pathogenicity. ...
6 CitationsSource
#1Tugba Arikoglu (Mersin University)H-Index: 7
#2Necdet Kuyucu (Mersin University)H-Index: 15
Last. Semanur Kuyucu (Mersin University)H-Index: 14
view all 4 authors...
Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency is a newly described syndrome characterized by severe congenital neutropenia associated with multiple organ abnormalities including cardiac and urogenital malformations. The underlying pathophysiology of increased apoptosis of myeloid cells and of neutrophil dysfunction in G6PC3 deficiency involves disturbed glucose metabolism, increased endoplasmic reticulum stress and deficient protein folding. Here, we report a new case of G6PC3 def...
4 CitationsSource